ArticleIranian journal of parasitology
Effectiveness of Attractive Toxic Sugar Baits (ATSB) in Reducing Cutaneous Leishmaniasis among Military Personnel in Isfahan Province, Central Part of Iran.
Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cutaneous leishmaniasis: emerging insights in epidemiology, diagnosis, and treatment.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aimed to evaluate the effectiveness of Attractive Toxic Sugar Baits (ATSB) in reducing the incidence of Cutaneous leishmaniasis (CL) among military personnel in Isfahan Province, Iran. Methods: The ATSB solution was prepared and applied to vegetation located approximately 500 meters from residential areas to target and eliminate sand fly vectors. Clinical samples were subsequently collected from individuals with suspected CL. The number of CL new cases among military personnel in 2022 was compared with collected historical data from 2012 to 2021, including the number of CL new cases, demographic characteristics, and seasonal incidence patterns. Statistical analysis was performed using ANOVA to assess whether the intervention led to a significant reduction in disease occurrence. Results: Following the application of ATSB, the new cases of CL among military personnel decreased from an average of 196 cases per year (2012-2021) to 55 cases in 2022. Seasonal analysis revealed a decline across all seasons, with the most notable reduction observed in autumn. Demographic analysis showed reductions in both male and female groups. However, statistical analysis using ANOVA indicated that the observed differences before and after the intervention were not statistically significant ( Conclusion: Despite a decline in CL case numbers in the studied areas, the reduction following ATSB application was not statistically significant. Nevertheless, ATSB may serve as a promising complementary approach for controlling CL in endemic regions. Further studies with larger sample sizes and extended follow-up periods are recommended to validate its effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.